Head-to-head · Cost-Efficiency Index
Teleios Health vs Brello Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Teleios Health
Shoppers comfortable calling or messaging before committing, since public pricing detail is minimal.
Visit Teleios HealthBrello Health
Shoppers comfortable with a mandatory 3-month auto-renewing commitment in exchange for a discounted per-month rate.
Visit Brello HealthThe verdict
Teleios Health takes it, leading the Cost-Efficiency Index 65 to 64. Teleios Health markets itself as a physician-led GLP-1 telehealth provider offering both compounded semaglutide and tirzepatide. Brello Health still earns a C — Shoppers comfortable with a mandatory 3-month auto-renewing commitment in exchange for a discounted per-month rate.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Teleios Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Teleios Health | Brello Health |
|---|---|---|
| Cost-Efficiency Index | 65/100 | 64/100 |
| Semaglutide / mo | $99/mo (all doses, compounded) | $133/mo (3-month plan, compounded) |
| Tirzepatide / mo | Not disclosed | $166/mo (3-month plan, compounded) |
| Semaglutide / yr (modeled) | $1,188 | $1,596 |
| Tirzepatide / yr (modeled) | — | $1,992 |
| Coverage | Coverage not published | 35 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #170 | #175 |
Teleios Health
65/100Where the value is
- Advertises a low $99/mo headline starting price, undercutting most compounded-GLP-1 competitors on paper
- Explicitly brands itself as 'physician-led,' setting an expectation of clinician oversight
- Discloses the standard compounded-medication FDA disclaimer up front rather than burying it
The tradeoffs
- No dose amount, drug, or inclusion breakdown is published for the $99/mo figure
- No visit fee, membership fee, or shipping fee disclosure could be found anywhere on the site
Brello Health
64/100Where the value is
- Discount structure is itemized transparently — both the discounted and pre-discount standing price are shown side by side ($133 vs $198 for semaglutide, $166 vs $247 for tirzepatide)
- Bundle options combining GLP-1 with NAD+ and/or Sermorelin are available on the same subscription
- The commitment mechanics are explicitly disclosed on-site ('3-month minimum commitment and automatically renew every 11 weeks') rather than buried in terms of service
The tradeoffs
- No month-to-month option exists at any price — every plan requires a 3-month minimum and auto-renews every 11 weeks, a real commitment a shopper comparing 'per month' prices across sites could easily miss
- The compounding pharmacy is not named, only 'USA-based 503A Partner Pharmacy,' and the site discloses it is mid-transition to a new facility
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.